SE9900438D0 - The pharmacological use of certian cystine derivatives - Google Patents

The pharmacological use of certian cystine derivatives

Info

Publication number
SE9900438D0
SE9900438D0 SE9900438A SE9900438A SE9900438D0 SE 9900438 D0 SE9900438 D0 SE 9900438D0 SE 9900438 A SE9900438 A SE 9900438A SE 9900438 A SE9900438 A SE 9900438A SE 9900438 D0 SE9900438 D0 SE 9900438D0
Authority
SE
Sweden
Prior art keywords
certian
pharmacological use
cystine derivatives
derivatives
cystine
Prior art date
Application number
SE9900438A
Other languages
Swedish (sv)
Inventor
Tommy Abrahamsson
Knut Pettersson
Goeran Walldius
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Priority to SE9900438A priority Critical patent/SE9900438D0/en
Publication of SE9900438D0 publication Critical patent/SE9900438D0/en
Priority to PCT/SE2000/000238 priority patent/WO2000047201A1/en
Priority to AU29540/00A priority patent/AU2954000A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

A method for the treatment and/or prophylaxis of endothelium dysfunction related diseases using certain cystine derivatives of general formula (I) and a pharmaceutical preparation comprising these derivatives.
SE9900438A 1999-02-10 1999-02-10 The pharmacological use of certian cystine derivatives SE9900438D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
SE9900438A SE9900438D0 (en) 1999-02-10 1999-02-10 The pharmacological use of certian cystine derivatives
PCT/SE2000/000238 WO2000047201A1 (en) 1999-02-10 2000-02-07 The pharmacological use of certain cystine derivatives
AU29540/00A AU2954000A (en) 1999-02-10 2000-02-07 The pharmacological use of certain cystine derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9900438A SE9900438D0 (en) 1999-02-10 1999-02-10 The pharmacological use of certian cystine derivatives

Publications (1)

Publication Number Publication Date
SE9900438D0 true SE9900438D0 (en) 1999-02-10

Family

ID=20414412

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9900438A SE9900438D0 (en) 1999-02-10 1999-02-10 The pharmacological use of certian cystine derivatives

Country Status (3)

Country Link
AU (1) AU2954000A (en)
SE (1) SE9900438D0 (en)
WO (1) WO2000047201A1 (en)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL98310A (en) * 1990-06-08 1996-08-04 Astra Ab Pharmaceutical compositions comprising cystine derivatives
TW221376B (en) * 1990-06-28 1994-03-01 Astra Ab
SE9103572D0 (en) * 1991-11-29 1991-11-29 Astra Ab ORGANIC SALTS OF N, N'-DIACETYL CYSTINE
SE9500897D0 (en) * 1995-03-14 1995-03-14 Astra Ab The pharmacological use of certain cysteine derivatives
SE9602416D0 (en) * 1996-06-18 1996-06-18 Astra Ab New forms of an organic salt of N'N-diacetylcystine

Also Published As

Publication number Publication date
WO2000047201A1 (en) 2000-08-17
AU2954000A (en) 2000-08-29

Similar Documents

Publication Publication Date Title
MY138352A (en) Benzothiazole derivatives
BR0109703A (en) Piperazine Derivatives
LU91928I2 (en) Ipilimumab and its pharmaceutically acceptable derivatives (YERVOY®)
IL165264A (en) Protein kinase inhibitors, pharmaceutical compositions comprising them and use thereof in the preparation of medicaments for treating protein kinase-associated diseases
JO2282B1 (en) Oxazol derivatives
DK1223980T3 (en) Use of CSF-1 Inhibitors
DE60124684D1 (en) SULPHONAMIDO-SUBSTITUTED BROKEN BICYCLOALKYL DERIVATIVES
DK1565471T3 (en) Quionolinylpyrazoles
ATE181080T1 (en) HIV PROTEASE INHIBITORS
BR0313747A (en) Non-nucleoside Reverse Transcriptase Inhibitors
TR200101120T2 (en) Serine protease inhibitor
CY1107465T1 (en) MELAGATRANI FOR THERAPEUTIC INFECTION
DE60121461D1 (en) CONDENSED PYRIDOINDOL DERIVATIVES
SE0101932D0 (en) Pharmaceutical combinations
NO20022470D0 (en) pyrimidine
PE20030061A1 (en) 1-BIARIL-1,8-NAPHTHYRIDIN-4-ONA AS PHOSPHODIESTERASE-4 INHIBITORS
EA200200742A1 (en) 1,2-DIARYLBENZYMIDAZOLEY FOR THE TREATMENT OF DISEASES ASSOCIATED WITH THE ACTIVATION OF MICROGLY
IT1318667B1 (en) ANTI-INFLAMMATORY DRUG.
DK0736029T3 (en) Anticonvulsant pseudofructopyranose sulfamates
PL360492A1 (en) Use of pamoic acid or one of its derivatives, or one of its analogues, for the preparation of a medicament for the treatment of diseases characterised by deposits of amyloid aggregates
GB9907571D0 (en) Compounds
EE200300129A (en) Use of distamycin alpha-haloacryloyl derivative
SE0004827D0 (en) Therapeutic compounds
DE60217315D1 (en) PHARMACEUTICAL COMPOSITIONS OF RAPAMYCINES
SE9900438D0 (en) The pharmacological use of certian cystine derivatives